AHA Coding Clinic® for ICD-9 - 2012 Issue 4; Volume 3 New/Revised Codes
Injection or Infusion of Glucarpidase
Effective October 1, 2012, a new procedure code (00.95) has been created to describe the administration of glucarpidase (Voraxaze®) used to treat cancer patients with toxic levels of methotrexate in their blood due to renal impairment. Prior to this change, the injection or infusion of glucarpidase was assigned to code 99.29, Injection or infusion of other therapeutic or prophylactic substance. Methotrexate is one of the most commonly used anti-cancer agents. The administration of high dose methotrexate is an important component in the treatment of a variety of cancers. One of the side effects of administering methotrexate...
To read the full article, sign in and subscribe to AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS .